Objectives. The purpose of this study was to evaluate the feasibility, safety and diagnostic accuracy of thallium-201 myocardial tomography with intravenous adenosine triphosphate (ATP) infusion in patients with suspected coronary artery disease.
Moreover, although the effect of ATP is proposed to be mostly dependent on its degradation to adenosine (7, 8) , direct stimulation of adenosine receptors by ATP itself cannot be fully excluded (9) (10) (11) . In this study we assessed the feasibility, safety, arid diagnostic accuracy of pharmacologic coronary vasodilation with ATP in combination with thallium-201 scintigraphy for diagnosing coronary artery disease in patients unable to perform an exercise test. Our results show that thallium-201 myocardial scintigraphy with ATP may have fewer side effects than that with adenosine.
Methods
Study patients (Table 1) . From September 1992 to August 1994, 253 consecutive patients (125 men, 128 women with a mean age of 68 _+ 11 years [range 38 to 89]) underwent thallium-201 myocardial scintigraphy with ATP for evaluation of possible coronary artery disease. These patients were judged to be physically unable to perform a conventional exercise stress test. All patients gave informed consent and the protocol was approved by the institutional review board of our hospital. The clinical characteristics of the patients are summarized in Table 1 .
Exclusion criteria for the study included recent myocardial infarction (within 2 weeks of the study), unstable angina, hypotension (systolic blood pressure <90 mm Hg), New York Heart Association class IV congestive heart failure, greater than first-degree atrioventricular (AV) block and asthma or chronic obstructive lung disease. Patients who were receiving theophylline, antianginal drugs or dipyridamole had these drugs discontinued for 24 h before the test. Caffeine ingestion was not allowed for ->12 h before the test.
Of the 253 patients, 120 (65 men, 55 women, mean age 67 _+ 9 years) also underwent coronary angiography for determination of sensitivity, specificity and predictive accuracy of thallium-201 myocardial tomography with ATP.
ATP infusion protocol. The ATP used in this study was supplied by Daiichi Pharm. Corp., Tokyo, as a sterile, isotonic aqueous solution at a concentration of 10 mg/ml (2-ml vials). Patients were studied in the fasting state in the supine position. The solution was infused over 5 min at a constant rate of 0.16 mg/min per kg body weight, through a peripheral venous catheter, with the use of an accurate computerized infusion pump system. After 3 rain of infusion, 111 MBq of thallium-201 was injected as a bolus into another venous site and flushed with 10 ml of normal saline solution, and the infusion continued for an additional 2 min. Three electrocardiographic (ECG) leads were continuously monitored throughout the test. Vital signs and a 12-lead ECG were recorded at baseline, during each minute of infusion and for at least 3 min after the ATP infusion. Perfusion imaging was begun at 5 min and again at 4 h after ATP infusion. Each patient was carefully monitored and questioned before, during and after termination of ATP infusion for the occurrence of adverse events. All adverse events were graded by physician investigators as mild, moderate or severe on the basis of clinical severity.
Thallium.201 myocardial emission computed tomography.
Thallium-201 myocardial perfusion imaging was performed by using a large field of view rotating gamma camera (Toshiba GCA 901A/SB, Tokyo) equipped with a low energy, high resolution collimator and interfaced to a computer (Toshiba GMS-550U). Images were acquired by means of a circular orbit over an anterior 180 ° arc from a 45 o right anterior oblique projection to a 45 o left posterior oblique projection. Each of 30 projections was acquired with the use of a 64 x 64 matrix for 30 s per projection.
Tomographic reconstruction was performed by means of a standard filtered back-projection technique with a Ramp filter to generate transaxial tomograms. No scatter or attenuation correction was applied. From these transaxial tomograms, the long axis of the left ventricle was identified and the obliqueangled tomograms were generated (i.e., the vertical long-axis, the short-axis and the horizontal long-axis slices) (Fig. 1, top) .
Interpretation of tomographic images. Visual analysis of the tomographic slices was performed by two experienced observers who were unaware of the ECG or coronary angiographic findings. The slices were displayed sequentially in all three cardiac planes to assess myocardial perfusion in each vascular territory. The presence or absence of redistribution was visually noted in the 4-h images. The vascular territories of the three major coronary arteries were assigned as follows: the septal and anterior segments corresponded to the left anterior descending coronary artery, the inferior and posterior segments to the right, and the lateral segments to the left circumflex coronary artery. Pure apical defects were considered abnormal but were not assigned to any individual coronary vessel.
Thallium-201 tomograms were quantified with the use of computerized two-dimensional polar (bull's-eye) maps of radionuclide activity (12) . The distribution of radioactivity was determined for each tomographic slice by using the eircumferemial profile technique. The normalized short-axis circumferential profiles were then color coded and displayed as concentric rings from the cardiac apex to the base. Apical images were defined from the short-and vertical long-axis slices and displayed in the center of the polar map. Then, the map of each patient was statistically compared with a normal data bank derived from 18 normal subjects who underwent thallium-201 myocardial tomography with ATP in our laboratory (including healthy volunteers with <5% probability of disease and subjects with normal angiographic findings). A pixel in a patient's polar map was considered abnormal (perfusion defect) if its count activity was >2.5 SD below the mean count for the corresponding pixel in the normal data bank. The initial polar maps obtained after the ATP infusion were used to quantify perfusion defects, and focal defects involving >3% of the total left ventricular pixels were considered abnormal ( Fig. 1 , bottom).
Coronary angiography. Selective coronary angiography
was performed with multiple views by using standard techniques. The mean time interval between coronary angiography and thallium-201 scintigraphy was 5 +-7 days (within 3 weeks). All angiograms were interpreted by two experienced angiographers without knowledge of the scintigraphic results. The severity of coronary stenosis was assessed by caliper measurements and expressed as percent lumen diameter stenosis. Stenoses >50% of the normal lumen diameter were considered significant. Data are presented as the mean value _+ SD when appropriate. Chi-square analysis and the Student t test were used for comparison. A p value < 0.05 was considered significant. (Table 2 ). The hemodynamic effects of intravenous ATP infusion are summarized in Table 2 . The infusion produced a significant increase in heart rate, a decrease in blood pressure and, thereby, no significant change in the rate-pressure product. Although systolic and diastolic blood pressure returned to baseline values _ 10 mm Hg in most patients within 3 min after the end of ATP infusion (68% and 86%, respectively), 16 patients (6%) had a paradoxic increase in systolic blood pressure and 8 (3%) had a paradoxic decrease in heart rate. (Table 3) . A total of 226 adverse events were reported by 141 patients (56%) and no events by 112 patients (44%). Table 3 shows the incidence of All values are expressed as mean value _+ SD. BP -blood pressure. No patient required premature termination of ATP or treatment with aminophylline. None died or had prolonged chest pain, acute myocardial infarction or ventricular arrhythmias. Six patients (2%) had AV block during the ATP infusion. Three of the six had asymptomatic second-degree AV block that resolved promptly within 1 rain of termination of ATP infusion; the remaining three patients had first-degree AV block. No patient had third-degree AV block. One of the 3 patients with transient second-degree AV block was one of the 4 patients in the total group of 253 patients who had firstdegree AV block before testing.
Results

Hemodynamic responses
Adverse effects of ATP infusion
Correlation between thallium-201 tomography and coronary angiography. Of the 120 patients who underwent coronary angiography, 76 had significant coronary artery disease (Table 4) . Coronary collateral vessels were observed in 22 patients. The perfusion defects were classified according to the degree of redistribution. Of the 76 patients with significant coronary artery disease, 9 had normal thallium-201 images, 38 had reversible perfusion defects, 12 had fixed defects only and 17 had both fixed and reversible defects determined by visual analysis of tomographic images.
The overall results are listed in Table 5 . The sensitivity and specificity were 88% and 80%, respectively, by visual analysis and 91% and 86% by computer quantification (p = NS comparing the two analyses). Of the six patients with normal (Table 4) .
Discussion
As many as 25% to 30% of patients with coronary artery disease may have a limited ability to achieve maximal exercise stress (13) . In patients unable to perform an exercise test, pharmacologic coronary vasodilation with dipyridamole has been used successfully in combination with thallium-201 scintigraphy as an alternative method of diagnosis in patients with suspected coronary artery disease (13, 14) . Although dipyridamole thallium-201 scintigraphy is generally a safe test, it frequently causes side effects that at times can be lifethreatening. Because of the prolonged effect of dipyridamole (15 to 30 min when given intravenously), it is often necessary to use intravenous aminophylline to reverse the side effects. Moreover, because the vasodilative action of dipyridamole is an indirect result of the elevation of endogenous adenosine levels, the degree of effect may vary among patients (15, 16) .
Thus, intravenous infusion of adenosine has been proposed as a means of achieving directly that which is an indirect effect of dipyridamole (1, 2) . Particular attractive aspects of adenosine for clinical pharmacologic vasodilation are its rapid onset of action and extremely short plasma half-life (<2 s). Several investigators (1-4) have reported that the diagnostic accuracy of adenosine thallium-201 scintigraphy is comparable to that of exercise or dipyridamole thallium-201 scintigraphy. However, they (17) have also reported a considerably high incidence of side effects, even though these side effects are mild and usually resolved within 1 to 2 min after termination of adenosine infusion. Among these side effects, the occasional occurrence of high degree AV block has attracted much attention. Like adenosine, ATP also has a short half-life in plasma (<20 s) and is rapidly metabolized as follows: ATP~adenosine diphosphate-->adenosine monophosphate~adenosine-* inosine-->hypoxanthine-->xanthine--+uric acid~allantoin (10) . Its degradation product, adenosine, can induce maximal coronary vasodilation through activation of purine receptors (A~ and A 2 membrane adenosine receptors) (18) . By using the Doppler catheter technique, Wilson et al. (5) found a 4.4-fold maximal increase in human coronary blood flow velocity at an infusion rate of 0.14 mg/kg per rain of adenosine. Recently, by using the same technique, it was reported (19) that the intravenous infusion of ATP at a rate >0.15 mg/kg per min was able to cause maximal coronary hyperemia similar to that caused by adenosine. In addition, ATP has been used to terminate paroxysmal supraventricular tachycardia. For that purpose, a much higher infusion rate of ATP has been used safely (8, 20) . Kinoshita et al. (21) also reported that there were no significant differences in side effects between the rate of 0.16 and that of 0.18 mg/kg per rain during ATP infusion.
Safety and feasibility of ATP seintigraphy. Although 56% of our patients experienced some adverse effects, these were mostly transient and mild and disappeared soon after termination of ATP infusion. Our ATP infusion protocol could be completed in all patients and no patient required aminophylline infusion for reversal of adverse effects. Cerqueira et al. (22) recently summarized the side effects from the Adenosine Multicenter Trial Registry (phase III trial), which included 9,256 patients. According to their summary, 81% of patients reported some adverse events, -20% required dose reduction or early termination because of intolerable side effects of adenosine, 0.8% required treatment with aminophylline. Whereas AV block occurred in 7.6% of their patients with adenosine infusion, it occurred in only 2% of our patients with ATP infusion.
Thus, our infusion protocol with ATP may have fewer side effects than that with adenosine. These results may be due to the breakdown time of ATP in plasma because it is gradually degraded to adenosine en route from a peripheral vein (the injection site) to the coronary sinus.
Ischemie ST segment depression during ATP infusion. Ischemic ST segment depression occurred in 40 patients (16%), of whom 35 (88%) had significant coronary artery disease and 33 (83%) had reversible defects by thallium-201 tomography. Thus, ST segment depression during ATP infusion seems to be a specific but not sensitive marker of reversible defects and significant coronary disease. Nishimura et al. (23) reported that the presence of coronary collateral vessels and adenosine-induced chest pain were significant predictors of ischemic ST segment depression in their patients with both angiographically documented coronary artery disease and abnormal perfusion defects on thallium-201 tomography. In our series, 19 patients (32%) with both significant coronary artery disease and transient perfusion defects had ischemic ST segment depression, whereas 41 (68%) did not.
The frequency of chest pain was significantly higher in patients with ST depression than in those without (63% vs. 34%, p = 0.03), whereas the frequency of collateral vessels was not.
Detection of coronary artery disease: clinical utility. The sensitivity of thallium-201 tomography with ATP using quantitative analysis was 91% and the specificity 86%; the sensitivity was 90% in one-vessel, 92% in two-vessel and 100% in three-vessel coronary artery disease. Using a similar quantitative analysis, Nishimura et al. (24) evaluated adenosine thallium tomography in 134 patients and reported that the sensitivity and specificity were 87% and 90%, respectively. Four other studies (1, 3, 4, 25) also reported that adenosine thallium tomography had a 83% to 92% sensitivity and a 75% to 94% specificity for detection of coronary artery disease. Our present results obtained with ATP stress are comparable to those obtained with adenosine stress or exercise stress.
Limitations of the study. Some of the limitations of our study need to be considered. 1) It is possible that patient selection bias may have enhanced the sensitivity of the test by including "sicker" patients (26) . However, this possibility seems unlikely because we excluded patients with acute myocardial infarction or unstable angina pectoris, and only 15% had previous Q-wave myocardial infarction. Also, -63% of the patients with significant coronary artery stenosis had onevessel stenosis. Furthermore, this bias would have resulted in a lower specificity. 2) We did not use a reinjection method in our thallium-201 imaging protocol; therefore, we may have underestimated the fraction of patients with ischemia as assessed by visual analysis. 3) We used a mixed gender normal data bank for quantitative analysis of perfusion defects. Nishimura et al. (27) also used a mixed gender normal data bank for quantitative analysis of adenosine thallium-201 tomography in 120 patients. They found that the normalcy rate for detection of coronary artery disease was high and comparable between men and women. 4) We did not measure the plasma ATP level or coronary blood flow. It was very difficult for us to measure local concentrations of ATP at the coronary sinus and peripheral veins because of the short half-life of ATP. Coronary blood flow measurements during various ATP infusion rates at various sites are now under way in our laboratory with use of the Doppler catheter technique.
Conclusions. Our results suggest that thallium-201 myocardial tomography with intravenous ATP infusion is a feasible technique and has a diagnostic value similar to that of intravenous adenosine infusion for detecting coronary artery disease in patients who are unable to exercise. In addition, thallium-201 scintigraphy with intravenous ATP infusion may have fewer side effects than that with intravenous adenosine infusion.
